Tina Witte

Boehringer hands PDT marketing rights to Click Therapeutics, pledges $50M firstwordpharma.com/story/7176194 via @fwpharma

AbbVie sues to narrow 340B eligibility firstwordpharma.com/story/7175275 via @fwpharma

Phase 3b Data Show Lilly’s EBGLYSS Sustains Skin Clearance and Itch Relief for Four Years in Atopic Dermatitis | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology americanpharmaceuticalreview.com/1315-News/6248… via @American Pharmaceutical Review

Sanofi eczema drug weighed down by mixed results, safety concerns biopharmadive.com/news/sanofi-to… via @BioPharmaDive

Patch developer rebrands, reels in $50M to fund pivot from vaccines to GLP-1s firstwordpharma.com/story/7148822 via @fwpharma

Daiichi Sankyo turns to Tempus AI to boost ADC development firstwordhealthtech.com/story/7147654 via @fwhealthtech

We’re taking action to accelerate earlier detection and improve care coordination for patients with ATTR-CM through a collaboration with @Viz_ai and support for the @American_Heart. Learn more: bit.ly/4uW4Dhp #ATTR #amyloidosis

Takeda targets $1.3B in cost savings in further restructuring fiercepharma.com/pharma/takeda-…

Immutrin raises $87M to advance drug for progressive heart disease biopharmadive.com/news/immutrin-… via @BioPharmaDive

Sarepta sees early success with RNAi drugs from Arrowhead biopharmadive.com/news/sarepta-a… via @BioPharmaDive

Apogee strengthens case for longer-lasting eczema drug biopharmadive.com/news/apogee-ec… via @BioPharmaDive

Novartis to pay $2B upfront for Pikavation and its portfolio targeting PI3Kα firstwordpharma.com/story/7142841 via @fwpharma

Walgreens Boots Alliance Launches Expanded Digital Health Platform for European Markets Including DACH Region firstwordhealthtech.com/story/7145011 via @fwhealthtech

For those in the #CellTherapy and #GeneTherapy space, this one is for you! #CGT #AdvancedTherapeutics #Innovation #Biotech fletchercsi.com/post/the-cgt-s…

J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections biopharmadive.com/news/jnj-psori… via @BioPharmaDive

Argo Biopharma Receives FDA Fast Track Designation for BW-20805, an Investigational siRNA Therapy for the Treatment of HAE finance.yahoo.com/news/argo-biop…

Sana’s Cell Therapy Sustains Insulin Production Through 14 Months in a T1D Patient biospace.com/drug-developme…

Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles biospace.com/business/pharm…

If you use AI, and are in a CI, strategy, or insights role, this is a must-read: #AI #Strategy #Insights fletchercsi.com/post/unsupervi…

FDA official hits back at uniQure, says Huntington's treatment is a 'failed therapy' firstwordpharma.com/story/7129420 via @fwpharma